IDT Australia FY21 Interim Results and Investor Update

Interim Results H1 FY21 Highlights COVID-19 Treatments and Vaccines – IDT Putting Forward Its Capabilities IDT’s business has continued to operate throughout the pandemic. During the reporting period the Company completed activities assisting the Federal Government in its initial COVID-19 response efforts. In August 2020 IDT made a formal submission to the Federal Government’s COVID-19 Vaccine and